510(k) Report

510(k) · Cleared

Recalled · Class II · 2023

Contour® next GEN Blood Glucose Monitoring System

K193407510(k) TraditionalCleared Dec 23, 2021745-day reviewClass II21 CFR 862.1345Recalls 1

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Ascensia Diabetes Care · NBW System, Test, Blood Glucose, Over The Counter

Cleared on Dec 23, 2021 as substantially equivalent to K160682 (Ascensia Diabetes Care, 2016) after a 745-day review. Its family tree reaches back 7 generations to 2003. 5 later devices descend from it. It has been recalled once.

Decided
Dec 23, 2021
Review
745 days
Class
Class II
Product code
NBW
Recalls
1
Predicates
1

Its longest line of descent runs back 7 generations to K030531 (2003). 10 ancestors in all. 5 later devices descend from it, 3 citing it directly.

  1. Root · 7 generations backK030531 Medtronic Minimed Paradigm Model 512 Insulin Pump and the BD…Minimed, Inc. · 2003 · Recalled
  2. 6 generations backK040603 Paradigm Link Blood Glucose MeterBecton, Dickinson & CO · 2004
  3. 5 generations backK073231 Onetouch Ultralink Blood Glucose Monitoring SystemLifescan, Inc. · 2008
  4. 4 generations backK110894 Contour Next Link Wireless Blood Glucose MeterBayer Healthcare · 2012
  5. 3 generations backK121087 Contour Next Usb Blood Glucose Monitoring SystemBayer Healthcare · 2012
  6. 2 generations backK150942 Contour Next USB Blood Glucose Monitoring SystemBayer Healthcare · 2015
  7. 1 generation backK160682 CONTOUR NEXT ONE Blood Glucose Monitoring SystemAscensia Diabetes Care · 2016
  8. This deviceK193407 Contour® next GEN Blood Glucose Monitoring SystemAscensia Diabetes Care · 2021
  9. Descendant · cites it directly · 2 of its ownK223293 CONTOUR® NEXT GEN Blood Glucose Monitoring SystemAscensia Diabetes Care U.S., Inc. · 2022
  10. Descendant · 2 generations on · 1 of its ownK241787 CONTOUR® PLUS BLUE Blood Glucose Monitoring System; CONTOUR® NEXT…Ascensia Diabetes Care U.S., Inc. · 2024
  11. Descendant · 3 generations on · 0 of its ownK260545 CONTOUR® PLUS BLUE Blood Glucose Monitoring System; CONTOUR® NEXT…Ascensia Diabetes Care · 2026
  12. Descendant · cites it directly · 0 of its ownK231679 CONTOUR® PLUS BLUE Blood Glucose Monitoring SystemAscensia Diabetes Care · 2024
  13. Descendant · cites it directly · 0 of its ownK231476 TRUENESS™ AIR Blood Glucose Monitoring System; TRUENESS™ Blood…Sinocare, Inc. · 2023

Most influential descendants

Showing 5 of 5 · See all
  • K223293CONTOUR® NEXT GEN Blood Glucose Monitoring SystemAscensia Diabetes Care U.S., Inc. · 2022 · cites it directly2descendants
  • K241787CONTOUR® PLUS BLUE Blood Glucose Monitoring System; CONTOUR® NEXT GEN Blood Glucose…Ascensia Diabetes Care U.S., Inc. · 2024 · 2 generations on1descendant
  • K260545CONTOUR® PLUS BLUE Blood Glucose Monitoring System; CONTOUR® NEXT GEN Blood Glucose…Ascensia Diabetes Care · 2026 · 3 generations on0descendants
  • K231679CONTOUR® PLUS BLUE Blood Glucose Monitoring SystemAscensia Diabetes Care · 2024 · cites it directly0descendants
  • K231476TRUENESS™ AIR Blood Glucose Monitoring System; TRUENESS™ Blood Glucose Monitoring SystemSinocare, Inc. · 2023 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−7K030531Medtronic Minimed Paradigm Model 512 Insulin Pump and the BD Paradigm Link…Minimed, Inc.20033
−6K040603Paradigm Link Blood Glucose MeterBecton, Dickinson & CO2004—
−5K073231Onetouch Ultralink Blood Glucose Monitoring SystemLifescan, Inc.2008—
−4K110894Contour Next Link Wireless Blood Glucose MeterBayer Healthcare2012—
−3K121087Contour Next Usb Blood Glucose Monitoring SystemBayer Healthcare2012—
−2K150942Contour Next USB Blood Glucose Monitoring SystemBayer Healthcare2015—
−1K160682CONTOUR NEXT ONE Blood Glucose Monitoring SystemAscensia Diabetes Care2016—
0 (this device)K193407Contour® next GEN Blood Glucose Monitoring SystemAscensia Diabetes Care2021—
+1K223293CONTOUR® NEXT GEN Blood Glucose Monitoring SystemAscensia Diabetes Care U.S., Inc.2022—
+2K241787CONTOUR® PLUS BLUE Blood Glucose Monitoring System; CONTOUR® NEXT GEN Blood…Ascensia Diabetes Care U.S., Inc.2024—
+3K260545CONTOUR® PLUS BLUE Blood Glucose Monitoring System; CONTOUR® NEXT GEN Blood…Ascensia Diabetes Care2026—
+1K231679CONTOUR® PLUS BLUE Blood Glucose Monitoring SystemAscensia Diabetes Care2024—
+1K231476TRUENESS™ AIR Blood Glucose Monitoring System; TRUENESS™ Blood Glucose…Sinocare, Inc.2023—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
200610
200710
200910

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202210
202310
202420
202610
FIG. 1 — Lineage of K193407, 2003–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in NBW? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new NBW device

  1. #1 K260545 CONTOUR® PLUS BLUE Blood Glucose Monitoring…score 14.6 · 10 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K160682CONTOUR NEXT ONE Blood Glucose Monitoring System
Summary page 4
…75 NBW; Glucose Test System, OTC 3) Predicate device: Contour® Next ONE Blood Glucose Monitoring System (K160682) 4) Device description: Contour® next GEN Blood Glucose Monitoring System is a blood glucose me…
Ascensia Diabetes Care2016—

Also cleared against K160682: 1 other device →

What descends from it? (5)

3 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K223293CONTOUR® NEXT GEN Blood Glucose Monitoring SystemAscensia Diabetes Care U.S., Inc.20222
K231679CONTOUR® PLUS BLUE Blood Glucose Monitoring SystemAscensia Diabetes Care20240
K231476TRUENESS™ AIR Blood Glucose Monitoring System; TRUENESS™ Blood Glucose Monitoring SystemSinocare, Inc.20230

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
May 19, 2023Class IIZ-2211-2023Process controlAscensia Diabetes Care has determined through customer complaints that 580 of 2900 meters from lot number DM01T033P are reconfigured from mg/dL to mmol/L. Among them, 579 meters distributed in the United States were packaged into the…

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 18 years and passes through 5 companies; a new generation was cleared every 3.4 years on median.
  • 1 of the 10 ancestors has a recall of any class.
  • Of its descendants, K223293 (Ascensia Diabetes Care U.S., Inc., 2022) has gone furthest, with 2 descendants of its own.
  • 1 other device also cites its predicate K160682.

How does its category compare?

All NBW devices

NBW System, Test, Blood Glucose, Over The Counter: FDA decisions, review times, recalls and adverse event reports over 20 years. 2021, this device’s year, is highlighted.

FDA decisions per year · NBW

2in 2025

2007: 292008: 372009: 382010: 312011: 302012: 302013: 472014: 242015: 322016: 202017: 252018: 192019: 102020: 72021: 72022: 122023: 52024: 72025: 22026 (partial year): 5
2007high 47 (2013) · low 2 (2025)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · NBW

243in 2024

2007: 85 days median2008: 128 days median2009: 140 days median2010: 132 days median2011: 328 days median2012: 230 days median2013: 167 days median2014: 202 days median2015: 237 days median2016: 233 days median2017: 244 days median2018: 168 days median2019: 127 days median2020: 121 days median2021: 465 days median2022: 410 days median2023: 193 days median2024: 243 days median2026 (partial year): 190 days median
2007high 465 (2021) · low 85 (2007)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · NBW

1in 2025

2007: 92008: 22009: 52010: 112011: 12012: 12013: 5, 2 Class I2014: 12016: 12019: 142025: 1
2007high 14 (2019) · low 0 (2015)2026

Class I (2 since 2007) Class II/III not classified

Adverse event reports per year · NBW

4,745in 2025

2007: 7,9912008: 7,7042009: 10,9632010: 11,6312011: 22,9092012: 23,4492013: 35,4082014: 38,5242015: 62,1112016: 76,6212017: 37,5382018: 16,9112019: 14,4722020: 10,7032021: 9,1982022: 8,1032023: 7,2562024: 6,2202025: 4,745
2007high 76,621 (2016) · low 4,745 (2025)2025

MAUDE reports naming product code NBW, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007298597,991
20083712827,704
200938140510,963
2010311321111,631
201130328122,909
201230230123,449
2013471675 (2)35,408
201424202138,524
201532237062,111
201620233176,621
201725244037,538
201819168016,911
2019101271414,472
20207121010,703
2021746509,198
20221241008,103
2023519307,256
2024724306,220
20252—14,745
202651900—

What is it indicated for?

The Contour® next GEN Blood Glucose Monitoring System consists of the Contour® next GEN meter, Contour® next test strips and the Contour® Diabetes app. The Contour® next Gen Blood Glucose Monitoring System is intended to be used for the quantitative measurement of glucose in fresh capillary whole blood drawn from the fingertips. The Contour® next GEN Blood Glucose Monitoring System is intended to be used by a single person and should not be shared. The…

Read the full statement (145 words)

The Contour® next GEN Blood Glucose Monitoring System consists of the Contour® next GEN meter, Contour® next test strips and the Contour® Diabetes app.

The Contour® next Gen Blood Glucose Monitoring System is intended to be used for the quantitative measurement of glucose in fresh capillary whole blood drawn from the fingertips. The Contour® next GEN Blood Glucose Monitoring System is intended to be used by a single person and should not be shared. The Contour® next GEN Blood Glucose Monitoring System is intended for self-testing outside the body (in vitro diagnostic use) by people with diabetes at home as an aid in monitoring the effectiveness of a diabetes control program.

The Contour® next GEN Blood Glucose Monitoring System should not be used for the diagnosis of or screening for diabetes or for neonatal use.

The system is intended for in vitro diagnostic use only.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K193407: Contour® next GEN Blood Glucose Monitoring System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K193407

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026